ET Government reports: US waives 100% tariffs on specialty drugs for 20 jurisdictions
What happened
The United States has announced zero import duties on select specialty medicines and components across 20 jurisdictions, including India. The decision waives a 100% tariff on products used for rare diseases, fertility treatments, and advanced therapies.
Why it matters
The exemption lowers import costs for critical treatments and preserves US market access for pharmaceutical manufacturers operating in India and the other designated regions.
Bigger picture
The targeted carve-out illustrates how regulators aim to safeguard vital healthcare supply chains while maintaining broader tariff policies across other economic sectors.
Watch next
Watch for detailed product lists from US authorities and subsequent adjustments to export volumes by affected drugmakers.